Atlas Trials

Multimodality- Adapted Dose Modification in Head and Neck Cancer Radiation Therapy 

Clinical trial NCT04933357 · UNKNOWN

Trial details

NCT number
NCT04933357
Sponsor
National Cancer Institute, Egypt
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2019-09-16
Primary completion
2022-09-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.